Franck Ceppa
Impact in
- Biotechnology top 2%
- Listeria monocytogenes in Food Safety
- Microbiology top 5%
- Bacterial Infections and Vaccines
Papers in
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 10
- Cholinesterase and Neurodegenerative Diseases 9
- Physiology 14
- Clinical Laboratory Practices and Quality Control 13
- Co-authors
- Pascal Burnat (25 shared papers)Hervé Delacour (23 shared papers)Herve Mayaudon (10 shared papers)Olivier Dupuy (8 shared papers)Bernard Bauduceau (8 shared papers)Patrick Masson (2 shared papers)Sofya V. Lushchekina (2 shared papers)Lawrence M. Schopfer (2 shared papers)
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)Diabetes & Metabolism (2 papers)The Lancet (1 paper)Annals of Pharmacotherapy (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceUnited StatesRussia
In The Last Decade
Franck Ceppa
56 papers receiving 966 citations
Franck Ceppa's Hit Papers
Peers
Comparison fields: 5 of 82
- Biotechnology 244
- Microbiology 89
- Pharmacology 49
- Pulmonary and Respiratory Medicine 155
- Anesthesiology and Pain Medicine 34
Countries citing papers authored by Franck Ceppa
This map shows the geographic impact of Franck Ceppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Ceppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Ceppa more than expected).
Fields of papers citing papers by Franck Ceppa
This network shows the impact of papers produced by Franck Ceppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Ceppa. The network helps show where Franck Ceppa may publish in the future.
Co-authors
The 25 scholars most cited alongside Franck Ceppa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 397 |
| 2 | 2006 | 161 | |
| 3 | 2004 | 59 | |
| 4 | 2020 | 41 | |
| 5 | 2005 | 37 | |
| 6 | 2000 | 33 | |
| 7 | 2014 | 33 | |
| 8 | 2014 | 26 | |
| 9 | 2010 | 21 | |
| 10 | 2016 | 18 | |
| 11 | 2007 | 12 | |
| 12 | 2008 | 11 | |
| 13 | Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1alpha in Africans with diabetes. | 2002 | 10 |
| 14 | 1997 | 9 | |
| 15 | 2005 | 9 | |
| 16 | 2005 | 9 | |
| 17 | 2007 | 9 | |
| 18 | 2002 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2007 | 6 |
About Franck Ceppa
Franck Ceppa is a scholar working on Pharmacology, Physiology, Pharmacology, Anesthesiology and Pain Medicine and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1k indexed citations. Recurring topics across this work include Clinical Laboratory Practices and Quality Control (13 papers), Pharmacogenetics and Drug Metabolism (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers), Anesthesia and Sedative Agents (7 papers), Pleural and Pulmonary Diseases (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Chronic Kidney Disease and Diabetes (2 papers) and Acute Myocardial Infarction Research (2 papers). The work is most often cited by research in Biotechnology (244 citations), Microbiology (89 citations), Pharmacology (49 citations), Pulmonary and Respiratory Medicine (155 citations) and Anesthesiology and Pain Medicine (34 citations). Franck Ceppa has collaborated with scholars based in France, United States and Russia. Frequent co-authors include Pascal Burnat, Hervé Delacour, Herve Mayaudon, Olivier Dupuy, Bernard Bauduceau, Patrick Masson, Sofya V. Lushchekina, Lawrence M. Schopfer, Oksana Lockridge and L. Bordier. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Diabetes & Metabolism, The Lancet, Annals of Pharmacotherapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.